Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis

British Journal of Dermatology

Volumn 176, Issue 3, 2017, Pages 667-676

  Thorneloe, R J ^a   Bundy, C ^a,b   Griffiths, C E M ^a,b   Ashcroft, D M ^a   Cordingley, L ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; CORTICOSTEROID; BIOLOGICAL FACTOR; DERMATOLOGICAL AGENT;

ADULT; AGED; ARTICLE; CHINESE MEDICINE; CLINICAL ARTICLE; COMMUNITY SAMPLE; CONTROLLED STUDY; COPING BEHAVIOR; DRUG ABUSE; EMOTIONAL STRESS; ENGLAND; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT-REPORTED OUTCOME; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; QUALITATIVE RESEARCH; SELF CARE; TOPICAL TREATMENT; TREATMENT REFUSAL; ATTITUDE TO HEALTH; CONFLICT; DOCTOR PATIENT RELATION; ETIOLOGY; MEDICATION COMPLIANCE; MENTAL STRESS; MIDDLE AGED; PSYCHOLOGY; RECURRENT DISEASE; SELF CONTROL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ATTITUDE TO HEALTH; BIOLOGICAL FACTORS; CONFLICT (PSYCHOLOGY); DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PSORIASIS; RECURRENCE; SELF-CONTROL; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 85015266327     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15086     Document Type: Article

References (49)

1. Parisi R, Symmons DPM, Griffiths CEM et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133:377–85.
2. Nevitt G, Hutchinson P. Psoriasis in the community: prevalence, severity and patients’ beliefs and attitudes towards the disease. Br J Dermatol 1996; 135:533–7.
3. DiMatteo MR, Giordani PJ, Lepper HS et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40:794–811.
4. Nieuwlaat R, Wilczynski N, Navarro T et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014; 11:CD000011.
5. Nijsten T, Margolis DJ, Feldman SR et al. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol 2005; 52:434–44.
6. Stern RS, Nijsten T, Feldman SR et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9:136–9.
7. Nelson PA, Barker Z, Griffiths CE et al. ‘On the surface’: a qualitative study of GPs’ and patients’ perspectives on psoriasis. BMC Fam Pract 2013; 14:158.
8. Storm A, Andersen SE, Benfeldt E et al. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 2008; 59:27–33.
9. Storm A, Benfeldt E, Andersen SE et al. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol 2008; 59:975–80.
10. Thorneloe R, Bundy C, Griffiths C et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol 2013; 168:20–31.
11. Carver CS, Scheier MF. On the Self-Regulation of Behavior. New York: Cambridge University Press, 1998.
12. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognit Ther Res 1992; 16:143–63.
13. Hagger MS, Orbell S. A meta-analytic review of the common-sense model of illness representations. Psychol Health 2003; 18:141–84.
14. Fortune DG, Richards HL, Main CJ et al. Pathological worrying, illness perceptions and disease severity in patients with psoriasis. Br J Health Psych 2000; 5:71–82.
15. Fortune DG, Richards HL, Griffiths CE et al. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41:157–74.
16. Scharloo M, Kaptein A, Weinman J et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res 1998; 44:573–85.
17. Scharloo M, Kaptein A, Weinman J et al. Patients’ illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 2000; 142:899–907.
18. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47:555–67.
19. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002; 17:17–32.
20. Horne R, Chapman SC, Parham R et al. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLOS ONE 2013; 8:e80633.
21. Baumeister RF, Heatherton TF. Self-regulation failure: an overview. Psychol Inq 1996; 7:1–15.
22. Pound P, Britten N, Morgan M et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005; 61:133–55.
23. Gladman DD, Antoni C, Mease P et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005; 64 (Suppl. 2):ii14–17.
24. Sommer DM, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2007; 298:321–8.
25. Cohen A, Dreiher J, Birkenfeld S. Psoriasis associated with ulcerative colitis and Crohn's disease. J Eur Acad Dermatol Venereol 2009; 23:561–5.
26. Gelfand JM, Neimann AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. J Am Acad Dermatol 2006; 296:1735–41.
27. Parisi R, Rutter MK, Lunt M et al. Psoriasis and the risk of major cardiovascular events: cohort study using the Clinical Practice Research Datalink. J Invest Dermatol 2015; 135:2189–97.
28. Kurd SK, Troxel AB, Crits-Christoph P et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010; 146:891–5.
29. Poikolainen K, Reunala T, Karvonen J et al. Alcohol intake: a risk factor for psoriasis in young and middle aged men? Br Med J 1990; 300:780–3.
30. Poikolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994; 130:473–7.
31. Naldi L, Conti A, Cazzaniga S et al. Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol 2014; 170:634–42.
32. Nijsten T, Wakkee M. Complexity of the association between psoriasis and comorbidities. J Invest Dermatol 2009; 129:1601–3.
33. Nelson P, Chew-Graham C, Griffiths C et al. Recognition of need in health care consultations: a qualitative study of people with psoriasis. Br J Dermatol 2013; 168:354–61.
34. Detweiler-Bedell JB, Friedman MA, Leventhal H et al. Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation. Clin Psychol Rev 2008; 28:1426–46.
35. Horne R, Parham R, Driscoll R et al. Patients’ attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:837–44.
36. Fortune DG, Richards HL, Kirby B et al. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients’ well-being. Br J Dermatol 2004; 151:1219–26.
37. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 14:1–24.
38. Ericsson KA, Simon HA. Protocol Analysis: Verbal Reports as Data. Cambridge, MA: Bradford Books/MIT Press, 1993.
39. Green C, Gilhooly K. Protocol analysis: practical implementation. In: Handbook of Qualitative Research Methods for Psychology and the Social Sciences (Richardson JTE, ed). Leicester: BPS Books, 1996; 55–74.
40. Moss-Morris R, Weinman J, Petrie K et al. The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002; 17:1–16.
41. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Analysing Qualitative Data. (Bryman A, Burgess R, eds). London: Routledge, 1994; 173–94.
42. O'Brien BC, Harris IB, Beckman TJ et al. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med 2014; 89:1245–51.
43. Baker CS, Foley PA, Braue A. Psoriasis uncovered – measuring burden of disease impact in a survey of Australians with psoriasis. Australas J Dermatol 2013; 54:1–6.
44. Dubertret L, Mrowietz U, Ranki A et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155:729–36.
45. Kimball AB, Gieler U, Linder D et al. Psoriasis: is the impairment to a patient's life cumulative? J Eur Acad Dermatol Venereol 2010; 24:989–1004.
46. Nelson P, Keyworth C, Chisholm A et al. ‘In someone's clinic but not in mine’ – clinicians’ views of supporting lifestyle behaviour change in patients with psoriasis: a qualitative interview study. Br J Dermatol 2014; 171:1116–22.
47. DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42:200–9.
48. National Institute for Health and Clinical Excellence. Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence (CG76). London: NICE, 2009.
49. Higginson S, Mansell W, Wood AM. An integrative mechanistic account of psychological distress, therapeutic change and recovery: the perceptual control theory approach. Clin Psychol Rev 2011; 31:249–59.